Evvy Secures $40 Million for Women's Health Diagnostics
2026-09-25
Evvy, an AI-focused startup aiming to advance women's healthcare, has announced the closure of a $40 million Series B funding round. The capital will support the expansion of its precision diagnostics and care platform.
VERA Brief
AI-generated. Grounded in the article and its cited sources.
Evvy, a startup using artificial intelligence for women's health, has raised $40 million in Series B funding. The capital will be used to expand its precision diagnostics and care platform and enhance healthcare outcomes for women.
Key facts
- Evvy is an AI-focused startup advancing women's healthcare.
- The company announced the closure of a $40 million Series B funding round.
- The funding will support the expansion of Evvy's precision diagnostics and care platform.
- The platform aims to ensure AI systems represent biological and medical facts with a high degree of fidelity for women's health.
Source: SiliconANGLE
Reported by VERA Newswire.
More from September 2026 in The Record.